keyword
MENU ▼
Read by QxMD icon Read
search

Ira AND tabas

keyword
https://www.readbyqxmd.com/read/27659679/an-imbalance-between-specialized-pro-resolving-lipid-mediators-and-pro-inflammatory-leukotrienes-promotes-instability-of-atherosclerotic-plaques
#1
Gabrielle Fredman, Jason Hellmann, Jonathan D Proto, George Kuriakose, Romain A Colas, Bernhard Dorweiler, E Sander Connolly, Robert Solomon, David M Jones, Eric J Heyer, Matthew Spite, Ira Tabas
Chronic unresolved inflammation plays a causal role in the development of advanced atherosclerosis, but the mechanisms that prevent resolution in atherosclerosis remain unclear. Here, we use targeted mass spectrometry to identify specialized pro-resolving lipid mediators (SPM) in histologically-defined stable and vulnerable regions of human carotid atherosclerotic plaques. The levels of SPMs, particularly resolvin D1 (RvD1), and the ratio of SPMs to pro-inflammatory leukotriene B4 (LTB4), are significantly decreased in the vulnerable regions...
September 23, 2016: Nature Communications
https://www.readbyqxmd.com/read/27437578/heart-disease-death-defying-plaque-cells
#2
COMMENT
Ira Tabas
No abstract text is available yet for this article.
August 4, 2016: Nature
https://www.readbyqxmd.com/read/27239042/hepatocyte-dach1-is-increased-in-obesity-via-nuclear-exclusion-of-hdac4-and-promotes-hepatic-insulin-resistance
#3
Lale Ozcan, Devram S Ghorpade, Ze Zheng, Jane Cristina de Souza, Ke Chen, Marc Bessler, Melissa Bagloo, Beth Schrope, Richard Pestell, Ira Tabas
Defective insulin signaling in hepatocytes is a key factor in type 2 diabetes. In obesity, activation of calcium/calmodulin-dependent protein kinase II (CaMKII) in hepatocytes suppresses ATF6, which triggers a PERK-ATF4-TRB3 pathway that disrupts insulin signaling. Elucidating how CaMKII suppresses ATF6 is therefore essential to understanding this insulin resistance pathway. We show that CaMKII phosphorylates and blocks nuclear translocation of histone deacetylase 4 (HDAC4). As a result, HDAC4-mediated SUMOylation of the corepressor DACH1 is decreased, which protects DACH1 from proteasomal degradation...
June 7, 2016: Cell Reports
https://www.readbyqxmd.com/read/27199481/mertk-cleavage-limits-proresolving-mediator-biosynthesis-and-exacerbates-tissue-inflammation
#4
Bishuang Cai, Edward B Thorp, Amanda C Doran, Manikandan Subramanian, Brian E Sansbury, Chyuan-Sheng Lin, Matthew Spite, Gabrielle Fredman, Ira Tabas
The acute inflammatory response requires a coordinated resolution program to prevent excessive inflammation, repair collateral damage, and restore tissue homeostasis, and failure of this response contributes to the pathology of numerous chronic inflammatory diseases. Resolution is mediated in part by long-chain fatty acid-derived lipid mediators called specialized proresolving mediators (SPMs). However, how SPMs are regulated during the inflammatory response, and how this process goes awry in inflammatory diseases, are poorly understood...
June 7, 2016: Proceedings of the National Academy of Sciences of the United States of America
https://www.readbyqxmd.com/read/27100066/targeted-interleukin-10-nanotherapeutics-developed-with-a-microfluidic-chip-enhance-resolution-of-inflammation-in-advanced-atherosclerosis
#5
Nazila Kamaly, Gabrielle Fredman, Jhalique Jane R Fojas, Manikandan Subramanian, Won Ii Choi, Katherine Zepeda, Cristian Vilos, Mikyung Yu, Suresh Gadde, Jun Wu, Jaclyn Milton, Renata Carvalho Leitao, Livia Rosa Fernandes, Moaraj Hasan, Huayi Gao, Vance Nguyen, Jordan Harris, Ira Tabas, Omid C Farokhzad
Inflammation is an essential protective biological response involving a coordinated cascade of signals between cytokines and immune signaling molecules that facilitate return to tissue homeostasis after acute injury or infection. However, inflammation is not effectively resolved in chronic inflammatory diseases such as atherosclerosis and can lead to tissue damage and exacerbation of the underlying condition. Therapeutics that dampen inflammation and enhance resolution are currently of considerable interest, in particular those that temper inflammation with minimal host collateral damage...
May 24, 2016: ACS Nano
https://www.readbyqxmd.com/read/26892964/macrophage-phenotype-and-function-in-different-stages-of-atherosclerosis
#6
REVIEW
Ira Tabas, Karin E Bornfeldt
The remarkable plasticity and plethora of biological functions performed by macrophages have enticed scientists to study these cells in relation to atherosclerosis for >50 years, and major discoveries continue to be made today. It is now understood that macrophages play important roles in all stages of atherosclerosis, from initiation of lesions and lesion expansion, to necrosis leading to rupture and the clinical manifestations of atherosclerosis, to resolution and regression of atherosclerotic lesions...
February 19, 2016: Circulation Research
https://www.readbyqxmd.com/read/26541678/how-an-artery-heals
#7
EDITORIAL
Kevin Jon Williams, Ira Tabas, Edward A Fisher
No abstract text is available yet for this article.
November 6, 2015: Circulation Research
https://www.readbyqxmd.com/read/26317499/suppression-of-adaptive-immune-cell-activation-does-not-alter-innate-immune-adipose-inflammation-or-insulin-resistance-in-obesity
#8
Manikandan Subramanian, Lale Ozcan, Devram Sampat Ghorpade, Anthony W Ferrante, Ira Tabas
Obesity-induced inflammation in visceral adipose tissue (VAT) is a major contributor to insulin resistance and type 2 diabetes. Whereas innate immune cells, notably macrophages, contribute to visceral adipose tissue (VAT) inflammation and insulin resistance, the role of adaptive immunity is less well defined. To address this critical gap, we used a model in which endogenous activation of T cells was suppressed in obese mice by blocking MyD88-mediated maturation of CD11c+ antigen-presenting cells. VAT CD11c+ cells from Cd11cCre+Myd88fl/fl vs...
2015: PloS One
https://www.readbyqxmd.com/read/26068544/treatment-of-obese-insulin-resistant-mice-with-an-allosteric-mapkapk2-3-inhibitor-lowers-blood-glucose-and-improves-insulin-sensitivity
#9
Lale Ozcan, Xiaoming Xu, Shi-Xian Deng, Devram S Ghorpade, Tiffany Thomas, Serge Cremers, Brian Hubbard, Michael H Serrano-Wu, Matthias Gaestel, Donald W Landry, Ira Tabas
The prevalence of obesity-induced type 2 diabetes (T2D) is increasing worldwide, and new treatment strategies are needed. We recently discovered that obesity activates a previously unknown pathway that promotes both excessive hepatic glucose production (HGP) and defective insulin signaling in hepatocytes, leading to exacerbation of hyperglycemia and insulin resistance in obesity. At the hub of this new pathway is a kinase cascade involving calcium/calmodulin-dependent protein kinase II (CaMKII), p38α mitogen-activated protein kinase (MAPK), and MAPKAPK2/3 (MK2/3)...
October 2015: Diabetes
https://www.readbyqxmd.com/read/25872946/c-ebp-homologous-protein-chop-in-vascular-smooth-muscle-cells-regulates-their-proliferation-in-aortic-explants-and-atherosclerotic-lesions
#10
Alex-Xianghua Zhou, Xiaobo Wang, Chyuan Sheng Lin, Jaeseok Han, Jing Yong, Marissa J Nadolski, Jan Borén, Randal J Kaufman, Ira Tabas
RATIONALE: Myeloid-derived C/EBP-homologous protein (CHOP), an effector of the endoplasmic reticulum stress-induced unfolded protein response, promotes macrophage apoptosis in advanced atherosclerosis, but the role of CHOP in vascular smooth muscle cells (VSMCs) in atherosclerosis is not known. OBJECTIVE: To investigate the role of CHOP in SM22α(+) VSMCs in atherosclerosis. METHODS AND RESULTS: Chop(fl/fl) mice were generated and crossed into the Apoe(-/-) and SM22α-CreKI(+) backgrounds...
May 22, 2015: Circulation Research
https://www.readbyqxmd.com/read/25869663/recent-insights-into-the-cellular-biology-of-atherosclerosis
#11
REVIEW
Ira Tabas, Guillermo García-Cardeña, Gary K Owens
Atherosclerosis occurs in the subendothelial space (intima) of medium-sized arteries at regions of disturbed blood flow and is triggered by an interplay between endothelial dysfunction and subendothelial lipoprotein retention. Over time, this process stimulates a nonresolving inflammatory response that can cause intimal destruction, arterial thrombosis, and end-organ ischemia. Recent advances highlight important cell biological atherogenic processes, including mechanotransduction and inflammatory processes in endothelial cells, origins and contributions of lesional macrophages, and origins and phenotypic switching of lesional smooth muscle cells...
April 13, 2015: Journal of Cell Biology
https://www.readbyqxmd.com/read/25695999/targeted-nanoparticles-containing-the-proresolving-peptide-ac2-26-protect-against-advanced-atherosclerosis-in-hypercholesterolemic-mice
#12
Gabrielle Fredman, Nazila Kamaly, Stefano Spolitu, Jaclyn Milton, Devram Ghorpade, Raymond Chiasson, George Kuriakose, Mauro Perretti, Omid Farokhzad, Omid Farokzhad, Ira Tabas
Chronic, nonresolving inflammation is a critical factor in the clinical progression of advanced atherosclerotic lesions. In the normal inflammatory response, resolution is mediated by several agonists, among which is the glucocorticoid-regulated protein called annexin A1. The proresolving actions of annexin A1, which are mediated through its receptor N-formyl peptide receptor 2 (FPR2/ALX), can be mimicked by an amino-terminal peptide encompassing amino acids 2-26 (Ac2-26). Collagen IV (Col IV)-targeted nanoparticles (NPs) containing Ac2-26 were evaluated for their therapeutic effect on chronic, advanced atherosclerosis in fat-fed Ldlr(-/-) mice...
February 18, 2015: Science Translational Medicine
https://www.readbyqxmd.com/read/25520521/accelerating-the-pace-of-atherosclerosis-research
#13
EDITORIAL
Alan Daugherty, Ira Tabas, Daniel J Rader
No abstract text is available yet for this article.
January 2015: Arteriosclerosis, Thrombosis, and Vascular Biology
https://www.readbyqxmd.com/read/25348165/identification-of-a-non-growth-factor-role-for-gm-csf-in-advanced-atherosclerosis-promotion-of-macrophage-apoptosis-and-plaque-necrosis-through-il-23-signaling
#14
Manikandan Subramanian, Edward Thorp, Ira Tabas
RATIONALE: Granulocyte macrophage colony-stimulating factor (GM-CSF, Csf2) is a growth factor for myeloid-lineage cells that has been implicated in the pathogenesis of atherosclerosis and other chronic inflammatory diseases. However, the role of GM-CSF in advanced atherosclerotic plaque progression, the process that gives rise to clinically dangerous plaques, is unknown. OBJECTIVE: To understand the role of GM-CSF in advanced atherosclerotic plaque progression. METHODS AND RESULTS: Ldlr(-/-) mice and Csf2(-/-)Ldlr(-/-) mice were fed a Western-type diet for 12 weeks, and then parameters of advanced plaque progression in the aortic root were quantified...
January 16, 2015: Circulation Research
https://www.readbyqxmd.com/read/25333768/a-solvent-free-thermosponge-nanoparticle-platform-for-efficient-delivery-of-labile-proteins
#15
Won Il Choi, Nazila Kamaly, Lorena Riol-Blanco, In-Hyun Lee, Jun Wu, Archana Swami, Cristian Vilos, Basit Yameen, Mikyung Yu, Jinjun Shi, Ira Tabas, Ulrich H von Andrian, Sangyong Jon, Omid C Farokhzad
Protein therapeutics have gained attention recently for treatment of a myriad of human diseases due to their high potency and unique mechanisms of action. We present the development of a novel polymeric thermosponge nanoparticle for efficient delivery of labile proteins using a solvent-free polymer thermo-expansion mechanism with clinical potential, capable of effectively delivering a range of therapeutic proteins in a sustained manner with no loss of bioactivity, with improved biological half-lives and efficacy in vivo...
November 12, 2014: Nano Letters
https://www.readbyqxmd.com/read/25246560/resolvin-d1-limits-5-lipoxygenase-nuclear-localization-and-leukotriene-b4-synthesis-by-inhibiting-a-calcium-activated-kinase-pathway
#16
Gabrielle Fredman, Lale Ozcan, Stefano Spolitu, Jason Hellmann, Matthew Spite, Johannes Backs, Ira Tabas
Imbalances between proinflammatory and proresolving mediators can lead to chronic inflammatory diseases. The balance of arachidonic acid-derived mediators in leukocytes is thought to be achieved through intracellular localization of 5-lipoxygenase (5-LOX): nuclear 5-LOX favors the biosynthesis of proinflammatory leukotriene B4 (LTB4), whereas, in theory, cytoplasmic 5-LOX could favor the biosynthesis of proresolving lipoxin A4 (LXA4). This balance is shifted in favor of LXA4 by resolvin D1 (RvD1), a specialized proresolving mediator derived from docosahexaenoic acid, but the mechanism is not known...
October 7, 2014: Proceedings of the National Academy of Sciences of the United States of America
https://www.readbyqxmd.com/read/25011473/camkii-in-cardiometabolic-disease
#17
EDITORIAL
Lale Ozcan, Ira Tabas
No abstract text is available yet for this article.
June 2014: Aging
https://www.readbyqxmd.com/read/24960242/camkii-in-cardiometabolic-disease
#18
Lale Ozcan, Ira Tabas
No abstract text is available yet for this article.
June 22, 2014: Aging
https://www.readbyqxmd.com/read/24902971/inflammation-and-its-resolution-as-determinants-of-acute-coronary-syndromes
#19
REVIEW
Peter Libby, Ira Tabas, Gabrielle Fredman, Edward A Fisher
Inflammation contributes to many of the characteristics of plaques implicated in the pathogenesis of acute coronary syndromes. Moreover, inflammatory pathways not only regulate the properties of plaques that precipitate acute coronary syndromes but also modulate the clinical consequences of the thrombotic complications of atherosclerosis. This synthesis will provide an update on the fundamental mechanisms of inflammatory responses that govern acute coronary syndromes and also highlight the ongoing balance between proinflammatory mechanisms and endogenous pathways that can promote the resolution of inflammation...
June 6, 2014: Circulation Research
https://www.readbyqxmd.com/read/24898746/common-therapeutic-targets-in-cardiometabolic-disease
#20
REVIEW
Gabrielle Fredman, Lale Ozcan, Ira Tabas
The interactions between cardiovascular disease (CVD) and insulin resistance syndromes suggest the possibility of joint targets for cardiometabolic research. The best drugs would go beyond minimizing adverse effects and have protective actions against both metabolic disease and CVD. In this perspective, we will outline a few examples in which a deep mechanistic understanding of the many cellular pathways that contribute to type 2 diabetes and CVD, regardless of cell type, have resulted in common upstream pathogenic pathways that can be therapeutically targeted...
June 4, 2014: Science Translational Medicine
keyword
keyword
107427
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"